News

News
Partner news

Cue Health Receives FDA Emergency Use Authorization for Its Rapid, Portable, Molecular Point-of-Care COVID-19 Test

Read full story
Partner news

Cue Health Closes $100 Million Series C Financing to Support Launch of Rapid Molecular Testing Platform

Read full story
Partner news

HistoSonics Announces $40 Million Financing

Read full story
Partner news

Imec collaborates with Janssen to advance precision medicine to treat and eliminate disease

Read full story
Partner news

DayTwo Secures $31 Million In Series B Financing To Scale Microbiome Research Platform To Address Chronic Health Conditions

Read full story
JNJ Press releases

Janssen Announces Collaboration with UC Berkeley, UCSF to Expand Data Science Research in Healthcare

Read full story
Partner news

Medicines Discovery Catapult, MQ: Transforming mental health and Alzheimer’s Research UK announce an innovative drug discovery consortium with industry, supported by the Wellcome Trust.

Read full story
Partner news

Navitor Pharmaceuticals Initiates a Clinical Study of NV-5138, a Novel, Oral Small Molecule for Treatment-Resistant Depression

Read full story
Partner news

Dreem Announces $35 Million Financing from lead investors Johnson & Johnson Innovation – JJDC, Inc. (JJDC) and Bpifrance to Accelerate Innovations in the Field of Sleep Science

Read full story
JNJ Press releases

Johnson & Johnson Innovation Opens JLABS @ NYC in Collaboration with New York State and the New York Genome Center

Read full story
JNJ Press releases

Johnson & Johnson Innovation Announces Launch of Shanghai Lung Cancer Innovation QuickFire Challenge

Read full story
Partner news

Evolve BioSystems Announces $40 Million Series C Financing to Expand its Flagship Infant Probiotic Product Evivo

Read full story
Partner news

E-Scape Bio Obtains Worldwide Rights from AbbVie for Selective S1P5 Program Targeting CNS-related Lysosomal Storage Disorders

Read full story
JNJ Press releases

Johnson & Johnson Innovation Announces Five-Year Alliance with Boston University to Accelerate Vision of World Without Lung Cancer

Read full story
JNJ Press releases

VIVUS Executes on its Strategic Vision with the Closing of its Acquisition of PANCREAZE® and Previously Announced Financing Transaction

Read full story